Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Achieve Life Sciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +12 vs. Q4 2023
- Shares held
- 16.5M
- +13.7M (+503.5%) vs. Q4 2023
- Total value
- $64.9M
- +$53.7M (+477.5%) vs. Q4 2023
- New holders
- 19
- 6 more added
- Sold out
- 7
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 1,047 | $5 | 0.00% | +1,047 | New |
| UBS Group AG | 2 | $9 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 5 | $23 | 0.00% | +5 | New |
| Cornerstone Planning Group LLC | 100 | $474 | 0.00% | +100 | New |
| Comerica Bank | 2,500 | $11.4K | 0.00% | 00.0% | Unchanged |
| Stephens Consulting, LLC | 3,000 | $13.6K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,142 | $14.3K | 0.00% | +430+15.9% | Added |
| Qube Research & Technologies Ltd | 4,029 | $18.3K | 0.00% | +4,028+402,800.0% | Added |
| Group One Trading, L.P. | 6,555 | $29.8K | 0.00% | −6,160−48.4% | Reduced |
| Advisor Group Holdings, Inc. | 9,852 | $44.8K | 0.00% | −50,000−83.5% | Reduced |
| Madison Park Capital Advisors, LLC | 10,000 | $45.5K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,700 | $49.0K | 0.00% | −200−1.8% | Reduced |
| Jefferies Financial Group Inc. | 11,500 | $52.3K | 0.00% | +11,500 | New |
| Omers Administration Corp | 12,000 | $54.5K | 0.00% | +12,000 | New |
| Virtu Financial LLC | 12,930 | $59.0K | 0.00% | +12,930 | New |
| Manchester Financial Inc | 19,100 | $86.8K | 0.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 22,218 | $101.0K | 0.00% | +22,218 | New |
| Bank of America Corp | 22,355 | $101.6K | 0.00% | +15,823+242.2% | Added |
| J. Goldman & Co LP | 24,548 | $111.6K | 0.01% | −42,953−63.6% | Reduced |
| Balyasny Asset Management LLC | 27,747 | $126.1K | 0.00% | +27,747 | New |
| Susquehanna International Group, LLP | 44,653 | $202.9K | 0.00% | +44,653 | New |
| BlackRock Inc. | 52,431 | $238.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 55,216 | $251.0K | 0.00% | −8,100−12.8% | Reduced |
| Wells Fargo & Company | 68,805 | $312.7K | 0.00% | −1,086−1.6% | Reduced |
| Northern Trust Corp | 98,732 | $448.7K | 0.00% | −3,252−3.2% | Reduced |
| Raymond James & Associates | 151,849 | $690.2K | 0.00% | −2,980−1.9% | Reduced |
| LPL Financial LLC | 182,500 | $829.5K | 0.00% | +4,000+2.2% | Added |
| Millennium Management LLC | 193,638 | $880.1K | 0.00% | +193,638 | New |
| Geode Capital Management, LLC | 206,784 | $940.1K | 0.00% | +21,859+11.8% | Added |
| Simplify Asset Management Inc. | 217,845 | $990.1K | 0.09% | +217,845 | New |
| Long Focus Capital Management, LLC | 248,099 | $1.13M | 0.13% | 00.0% | Unchanged |
| Shay Capital LLC | 450,000 | $2.05M | 0.60% | −275,000−37.9% | Reduced |
| Alyeska Investment Group, L.P. | 471,000 | $2.14M | 0.01% | +471,000 | New |
| CVI Holdings, LLC | 567,192 | $2.58M | 2.43% | +567,192 | New |
| Nantahala Capital Management, LLC | 654,000 | $2.97M | 0.29% | +654,000 | New |
| Altium Capital Management LP | 835,470 | $3.80M | 1.70% | +835,470 | New |
| ADAR1 Capital Management, LLC | 875,000 | $3.98M | 1.09% | +875,000 | New |
| Vanguard Group Inc | 948,441 | $4.31M | 0.00% | +342,731+56.6% | Added |
| Sofinnova Investments, Inc. | 1,518,230 | $6.90M | 0.41% | +1,518,230 | New |
| Propel Bio Management, LLC | 2,453,092 | $11.1M | 6.49% | +2,453,092 | New |
| Franklin Resources Inc | 5,964,088 | $17.2M | 0.01% | +5,964,088 | New |
| Walleye Capital LLC | 0 | $0 | 0.00% | −82,599−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −23,105−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −18,753−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −11,441−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −11,560−100.0% | Sold out |
| Godsey & Gibb Associates | 0 | $0 | 0.00% | −453−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |